Estimation of disease incidence in claims data dependent on the length of follow-up: a methodological approach

Health Serv Res. 2012 Apr;47(2):746-55. doi: 10.1111/j.1475-6773.2011.01325.x.

Abstract

Objective: To analyze the impact of the length of disease-free intervals on incidence estimation.

Data source: Statutory health insurance sample in Germany.

Study design: Overestimation of the incidence in the first quarter of 2008 for three selected diseases, diabetes mellitus, colorectal cancer, and heart failure, depending on different lengths of preceding disease-free intervals.

Data collection/extraction methods: Continuously insured from 2000 until 2008 ≥ 18 years (N = 144,907).

Principal findings: Compared with an 8-year disease-free period, incidence overestimations for diabetes, colorectal cancer, and heart failure were 40, 23, and 43 percent defining a 1-year, and 5, 9, and 5 percent defining a 5-year disease-free period, respectively.

Conclusions: Depending on the specific disease, caution has to be taken while using short disease-free periods because incidence estimates may be extremely overestimated.

MeSH terms

  • Colorectal Neoplasms / epidemiology
  • Diabetes Mellitus / epidemiology
  • Female
  • Follow-Up Studies
  • Germany / epidemiology
  • Heart Failure / epidemiology
  • Humans
  • Incidence*
  • Insurance Claim Reporting / statistics & numerical data*
  • Male
  • Middle Aged
  • Statistics as Topic
  • Time Factors